Literature DB >> 6726080

A study of the small spherical high density lipoproteins of patients afflicted with familial lecithin: cholesterol acyltransferase deficiency.

C Chen, K Applegate, W C King, J A Glomset, K R Norum, E Gjone.   

Abstract

We studied the effects of the lecithin:cholesterol acyltransferase reaction on the size and composition of the small spherical high density lipoproteins of patients afflicted with familial lecithin:cholesterol acyltransferase deficiency. We isolated these lipoproteins by preparative ultracentrifugation and rate zonal ultracentrifugation, determined their diameter by gradient gel electrophoresis, and then calculated their composition by relating measurements of their lipid and apolipoprotein content to particle volume. Our results revealed lipoprotein particles 6.0-6.2 nm in diameter that contained approximately 2 molecules of apolipoprotein A-I, 37-38 molecules of phospholipid, 3-9 molecules of unesterified cholesterol, 1-2 molecules of cholesteryl ester, and 1-2 molecules of triacylglycerol. Upon being incubated with lecithin:cholesterol acyltransferase and a source of additional unesterified cholesterol, these lipoproteins increased in content of total cholesterol and in particle size to form discrete lipoprotein products 6.6-8.6 nm in diameter. The increase in size occurred despite a net decrease in product unesterified cholesterol and phospholipid and though the net change in total lipid volume was small. Moreover, specific product lipoproteins, isolated by rate zonal ultracentrifugation, contained an increased amount of apolipoprotein A-I. These results seem best explained by a process involving lecithin:cholesterol acyltransferase-induced particle rearrangement reactions. The possibility that a similar process normally occurs in vivo deserves to be explored.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6726080

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  4 in total

1.  Isolation of a high-density-lipoprotein conversion factor from human plasma. A possible role of apolipoprotein A-IV as its activator.

Authors:  P J Barter; O V Rajaram; L B Chang; K A Rye; P Gambert; L Lagrost; C Ehnholm; N H Fidge
Journal:  Biochem J       Date:  1988-08-15       Impact factor: 3.857

2.  Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.

Authors:  D J Rader; K Ikewaki; N Duverger; H Schmidt; H Pritchard; J Frohlich; M Clerc; M F Dumon; T Fairwell; L Zech
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

3.  Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism.

Authors:  O L Francone; E L Gong; D S Ng; C J Fielding; E M Rubin
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

4.  Familial lecithin-cholesterol acyltransferase (LCAT) deficiency; a differential of proteinuria.

Authors:  Mohammed Mahdi Althaf; Hadeel Almana; Ahmed Abdelfadiel; Sadiq Mohammed Amer; Turki Omar Al-Hussain
Journal:  J Nephropathol       Date:  2015-01-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.